Investing.com - Edwards Lifesciences (NYSE:EW) reported third quarter earnings that beat analysts' expectations on Wednesday and revenue that fell short of forecasts.
The firm reported earnings per share of $0.54 on revenue of $1.31B. Analysts polled by Investing.com anticipated EPS of $0.5326 on revenue of $1.32B. .
Edwards Lifesciences shares lost 6.74% to trade at $108.25 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are up 76%, outperforming the S&P Global 100 which is up 17.93% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On Tuesday, October 19, 2021, J&J reported third quarter EPS of $2.6 on revenue of $23.34B, compared to forecasts of EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific earnings beat analyst's expectations on Wednesday, with third quarter EPS of $5.76 on revenue of $9.33B. Investing.com analysts expected EPS of $4.68 on revenue of $8.33B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar